The medical exoskeleton market value is estimated to be US$ 394.3 million in 2024. Global population aging is on the rise, creating a greater need for assistive exoskeleton devices for regular activities or rehabilitation.
The market is predicted to rise at a robust CAGR of 29.1% during the forecast period. The global medical exoskeleton industry's share is estimated to reach a value of nearly US$ 5,100 million by 2034.
Medical Exoskeleton Market Trends & Analysis
| Report Attribute | Details |
|---|---|
| Medical Exoskeleton Market Size (2024) | US$ 394.3 million |
| Market Anticipated Forecast Value (2034) | US$ 5,100 million |
| Market Projected Growth Rate (2024 to 2034) | 29.1% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The net revenue generated from sales of medical exoskeletons globally was US$ 98 million in 2019. In the following years, the sales increased at an astounding rate of 38.4% on average till 2023. The overall market value was US$ 301 million in 2023.
A move toward home-based healthcare solutions or rehabilitating in-home settings surged the sales of exoskeleton suits during this period. This trend is likely to continue ahead and drive the market growth over the next ten years.
| Attributes | Details |
|---|---|
| Medical Exoskeleton Market Value (2019) | US$ 98 million |
| Market Revenue (2023) | US$ 301 million |
| Market Historical Growth Rate (CAGR 2019 to 2023) | 38.4% CAGR |
As per recent global health reports, neurological problems are becoming more common among all age groups, affecting the mobility of limbs and the body. So, the development of exoskeletons by combining different sensors and algorithms for better obstacle recognition, motion tracking, and stability is likely to get popular among patients suffering from diseases like spinal cord injuries and stroke.
Combining augmented reality (AR) and virtual reality (VR), like immersive technologies, is a current trend to improve patients' rehabilitation experience. The integration of more modern aids to make wearable exoskeleton devices more engaging and effective has increased their demand and use in old-age homes or rehabilitation facilities.
Principal Consultant
The table below lists the countries with higher estimated CAGRs as per the medical exoskeleton industry analysis report for 2024 to 2034.
| Regional Market Comparison | CAGR (2024 to 2034) |
|---|---|
| United States | 28.6% |
| Japan | 30.7% |
| United Kingdom | 29.8% |
| South Korea | 31.4% |
| China | 30.2% |
The United States medical exoskeleton market is projected to grow at a rate of 28.6% through the forecasted years. The net worth of this leading market is poised to be around US$ 911.1 million by 2034.
Demand for medical exoskeletons in the United Kingdom is expected to increase at a rate of 29.8% per year till 2034. The United Kingdom market valuation is expected to reach almost US$ 207.2 million by 2034 end.
The medical exoskeleton industry in China is forecasted to advance at a rate of 30.2% over the forecast years. The net worth of the regional market is expected to reach US$ 830.5 million by 2034.
Production and sales of medical exoskeletons in Japan are likely to increase at a promising rate of 30.7% during the forecast years. Net revenue generated by the regional medical exoskeleton manufacturers here is expected to be US$ 593.2 million by 2034.
The medical exoskeleton industries in South Korea are poised to witness the most lucrative growth rate of 31.4% on average between 2024 and 2034. Their combined valuation by 2034 end is forecasted to be around US$ 297.9 million.
Based on product type, powered exoskeleton devices are leading the market. This segment is expected to witness a growth rate of 28.8% over the next ten years.
| Attributes | Details |
|---|---|
| Top Product Type or Segment | Powered Exoskeleton |
| Market Segment Growth Rate from 2024 to 2034 | 28.8% CAGR |
| Market Segment Growth Rate from 2019 to 2023 | 32.1% CAGR |
Based on mobility type, the stationary exoskeleton segment dominates over the mobile exoskeleton segment. The stationary exoskeleton segment is forecasted to further expand at a rate of 28.5% per year through 2034.
| Attributes | Details |
|---|---|
| Top Mobility Type or segment | Stationary Exoskeleton |
| Market Segment Growth Rate from 2024 to 2034 | 28.5% CAGR |
| Market Segment Growth Rate from 2019 to 2023 | 31.8% CAGR |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The overall market is comparatively less competitive as very few companies have been able to establish a successful business with the necessary technology and infrastructure. By providing choices for financing, leading medical exoskeletons are attracting patients struggling financially, thereby motivating medical institutions to use their products more.
Meanwhile, new market players are adopting the strategy of working along with medical facilities and rehabilitation institutes to scale up their businesses fast and increase market presence.
Recent Developments in the Global Medical Exoskeleton Market
| Attribute | Details |
|---|---|
| Estimated Market Size (2024) | US$ 394.3 million |
| Projected Market Size (2034) | US$ 5,100 million |
| Anticipated Growth Rate (2024 to 2034) | 29.1% |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | US$ million or billion for Value and Units for Volume |
| Key Regions Covered | North America, Latin America, Europe, Middle East & Africa (MEA), East Asia, South Asia and Oceania |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Germany, Spain, Italy, France, United Kingdom, Russia, China, India, Australia & New Zealand, GCC Countries, and South Africa |
| Key Segments Covered | By Product Type, By Application, By Mobility, By Component, and By Region |
| Key Companies Profiled |
|
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The global medical exoskeleton market is estimated to be US$ 394.3 million in 2024.
The global medical exoskeleton market is to grow at 29.1% during the forecast period.
The global medical exoskeleton market is to be valued at US$ 5,100 million by 2034.
The global medical exoskeleton market was valued at US$ 98 million in 2019.
China accounts for nearly 16% share of the global medical exoskeleton market.
South Korea to witness a CAGR of 31.4% in sales of medical exoskeletons through 2034.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023 4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Type, 2019 to 2023 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2024 to 2034 5.3.1. Powered exoskeleton 5.3.2. Passive exoskeleton 5.4. Y-o-Y Growth Trend Analysis By Type, 2019 to 2023 5.5. Absolute $ Opportunity Analysis By Type, 2024 to 2034 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Mobility 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Mobility, 2019 to 2023 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Mobility, 2024 to 2034 6.3.1. Stationary 6.3.2. Mobile 6.4. Y-o-Y Growth Trend Analysis By Mobility, 2019 to 2023 6.5. Absolute $ Opportunity Analysis By Mobility, 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Component 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Component, 2019 to 2023 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Component, 2024 to 2034 7.3.1. Hardware 7.3.2. Software 7.4. Y-o-Y Growth Trend Analysis By Component, 2019 to 2023 7.5. Absolute $ Opportunity Analysis By Component, 2024 to 2034 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) Analysis By Application, 2019 to 2023 8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2024 to 2034 8.3.1. Spinal Cord Injury 8.3.2. Stroke 8.3.3. Others 8.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023 8.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023 9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034 9.3.1. North America 9.3.2. Latin America 9.3.3. Western Europe 9.3.4. Eastern Europe 9.3.5. South Asia and Pacific 9.3.6. East Asia 9.3.7. Middle East and Africa 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 10.2.1. By Country 10.2.1.1. USA 10.2.1.2. Canada 10.2.2. By Type 10.2.3. By Mobility 10.2.4. By Component 10.2.5. By Application 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Type 10.3.3. By Mobility 10.3.4. By Component 10.3.5. By Application 10.4. Key Takeaways 11. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Type 11.2.3. By Mobility 11.2.4. By Component 11.2.5. By Application 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Type 11.3.3. By Mobility 11.3.4. By Component 11.3.5. By Application 11.4. Key Takeaways 12. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. UK 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Rest of Western Europe 12.2.2. By Type 12.2.3. By Mobility 12.2.4. By Component 12.2.5. By Application 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Type 12.3.3. By Mobility 12.3.4. By Component 12.3.5. By Application 12.4. Key Takeaways 13. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 13.2.1. By Country 13.2.1.1. Poland 13.2.1.2. Russia 13.2.1.3. Czech Republic 13.2.1.4. Romania 13.2.1.5. Rest of Eastern Europe 13.2.2. By Type 13.2.3. By Mobility 13.2.4. By Component 13.2.5. By Application 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Type 13.3.3. By Mobility 13.3.4. By Component 13.3.5. By Application 13.4. Key Takeaways 14. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 14.2.1. By Country 14.2.1.1. India 14.2.1.2. Bangladesh 14.2.1.3. Australia 14.2.1.4. New Zealand 14.2.1.5. Rest of South Asia and Pacific 14.2.2. By Type 14.2.3. By Mobility 14.2.4. By Component 14.2.5. By Application 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Type 14.3.3. By Mobility 14.3.4. By Component 14.3.5. By Application 14.4. Key Takeaways 15. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 15.2.1. By Country 15.2.1.1. China 15.2.1.2. Japan 15.2.1.3. South Korea 15.2.2. By Type 15.2.3. By Mobility 15.2.4. By Component 15.2.5. By Application 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Type 15.3.3. By Mobility 15.3.4. By Component 15.3.5. By Application 15.4. Key Takeaways 16. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 16.2.1. By Country 16.2.1.1. GCC Countries 16.2.1.2. South Africa 16.2.1.3. Israel 16.2.1.4. Rest of MEA 16.2.2. By Type 16.2.3. By Mobility 16.2.4. By Component 16.2.5. By Application 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Type 16.3.3. By Mobility 16.3.4. By Component 16.3.5. By Application 16.4. Key Takeaways 17. Key Countries Market Analysis 17.1. USA 17.1.1. Pricing Analysis 17.1.2. Market Share Analysis, 2023 17.1.2.1. By Type 17.1.2.2. By Mobility 17.1.2.3. By Component 17.1.2.4. By Application 17.2. Canada 17.2.1. Pricing Analysis 17.2.2. Market Share Analysis, 2023 17.2.2.1. By Type 17.2.2.2. By Mobility 17.2.2.3. By Component 17.2.2.4. By Application 17.3. Brazil 17.3.1. Pricing Analysis 17.3.2. Market Share Analysis, 2023 17.3.2.1. By Type 17.3.2.2. By Mobility 17.3.2.3. By Component 17.3.2.4. By Application 17.4. Mexico 17.4.1. Pricing Analysis 17.4.2. Market Share Analysis, 2023 17.4.2.1. By Type 17.4.2.2. By Mobility 17.4.2.3. By Component 17.4.2.4. By Application 17.5. Germany 17.5.1. Pricing Analysis 17.5.2. Market Share Analysis, 2023 17.5.2.1. By Type 17.5.2.2. By Mobility 17.5.2.3. By Component 17.5.2.4. By Application 17.6. UK 17.6.1. Pricing Analysis 17.6.2. Market Share Analysis, 2023 17.6.2.1. By Type 17.6.2.2. By Mobility 17.6.2.3. By Component 17.6.2.4. By Application 17.7. France 17.7.1. Pricing Analysis 17.7.2. Market Share Analysis, 2023 17.7.2.1. By Type 17.7.2.2. By Mobility 17.7.2.3. By Component 17.7.2.4. By Application 17.8. Spain 17.8.1. Pricing Analysis 17.8.2. Market Share Analysis, 2023 17.8.2.1. By Type 17.8.2.2. By Mobility 17.8.2.3. By Component 17.8.2.4. By Application 17.9. Italy 17.9.1. Pricing Analysis 17.9.2. Market Share Analysis, 2023 17.9.2.1. By Type 17.9.2.2. By Mobility 17.9.2.3. By Component 17.9.2.4. By Application 17.10. Poland 17.10.1. Pricing Analysis 17.10.2. Market Share Analysis, 2023 17.10.2.1. By Type 17.10.2.2. By Mobility 17.10.2.3. By Component 17.10.2.4. By Application 17.11. Russia 17.11.1. Pricing Analysis 17.11.2. Market Share Analysis, 2023 17.11.2.1. By Type 17.11.2.2. By Mobility 17.11.2.3. By Component 17.11.2.4. By Application 17.12. Czech Republic 17.12.1. Pricing Analysis 17.12.2. Market Share Analysis, 2023 17.12.2.1. By Type 17.12.2.2. By Mobility 17.12.2.3. By Component 17.12.2.4. By Application 17.13. Romania 17.13.1. Pricing Analysis 17.13.2. Market Share Analysis, 2023 17.13.2.1. By Type 17.13.2.2. By Mobility 17.13.2.3. By Component 17.13.2.4. By Application 17.14. India 17.14.1. Pricing Analysis 17.14.2. Market Share Analysis, 2023 17.14.2.1. By Type 17.14.2.2. By Mobility 17.14.2.3. By Component 17.14.2.4. By Application 17.15. Bangladesh 17.15.1. Pricing Analysis 17.15.2. Market Share Analysis, 2023 17.15.2.1. By Type 17.15.2.2. By Mobility 17.15.2.3. By Component 17.15.2.4. By Application 17.16. Australia 17.16.1. Pricing Analysis 17.16.2. Market Share Analysis, 2023 17.16.2.1. By Type 17.16.2.2. By Mobility 17.16.2.3. By Component 17.16.2.4. By Application 17.17. New Zealand 17.17.1. Pricing Analysis 17.17.2. Market Share Analysis, 2023 17.17.2.1. By Type 17.17.2.2. By Mobility 17.17.2.3. By Component 17.17.2.4. By Application 17.18. China 17.18.1. Pricing Analysis 17.18.2. Market Share Analysis, 2023 17.18.2.1. By Type 17.18.2.2. By Mobility 17.18.2.3. By Component 17.18.2.4. By Application 17.19. Japan 17.19.1. Pricing Analysis 17.19.2. Market Share Analysis, 2023 17.19.2.1. By Type 17.19.2.2. By Mobility 17.19.2.3. By Component 17.19.2.4. By Application 17.20. South Korea 17.20.1. Pricing Analysis 17.20.2. Market Share Analysis, 2023 17.20.2.1. By Type 17.20.2.2. By Mobility 17.20.2.3. By Component 17.20.2.4. By Application 17.21. GCC Countries 17.21.1. Pricing Analysis 17.21.2. Market Share Analysis, 2023 17.21.2.1. By Type 17.21.2.2. By Mobility 17.21.2.3. By Component 17.21.2.4. By Application 17.22. South Africa 17.22.1. Pricing Analysis 17.22.2. Market Share Analysis, 2023 17.22.2.1. By Type 17.22.2.2. By Mobility 17.22.2.3. By Component 17.22.2.4. By Application 17.23. Israel 17.23.1. Pricing Analysis 17.23.2. Market Share Analysis, 2023 17.23.2.1. By Type 17.23.2.2. By Mobility 17.23.2.3. By Component 17.23.2.4. By Application 18. Market Structure Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Market Share Analysis of Top Players 18.3.1. By Regional 18.3.2. By Type 18.3.3. By Mobility 18.3.4. By Component 18.3.5. By Application 19. Competition Analysis 19.1. Competition Deep Dive 19.1.1. CYBERDYNE INC. 19.1.1.1. Overview 19.1.1.2. Product Portfolio 19.1.1.3. Profitability by Market Segments 19.1.1.4. Sales Footprint 19.1.1.5. Strategy Overview 19.1.1.5.1. Marketing Strategy 19.1.2. Wearable Robotics srl 19.1.2.1. Overview 19.1.2.2. Product Portfolio 19.1.2.3. Profitability by Market Segments 19.1.2.4. Sales Footprint 19.1.2.5. Strategy Overview 19.1.2.5.1. Marketing Strategy 19.1.3. B-Temia 19.1.3.1. Overview 19.1.3.2. Product Portfolio 19.1.3.3. Profitability by Market Segments 19.1.3.4. Sales Footprint 19.1.3.5. Strategy Overview 19.1.3.5.1. Marketing Strategy 19.1.4. Rewalk Robotics 19.1.4.1. Overview 19.1.4.2. Product Portfolio 19.1.4.3. Profitability by Market Segments 19.1.4.4. Sales Footprint 19.1.4.5. Strategy Overview 19.1.4.5.1. Marketing Strategy 19.1.5. DIH Medical 19.1.5.1. Overview 19.1.5.2. Product Portfolio 19.1.5.3. Profitability by Market Segments 19.1.5.4. Sales Footprint 19.1.5.5. Strategy Overview 19.1.5.5.1. Marketing Strategy 19.1.6. Ekso Bionics 19.1.6.1. Overview 19.1.6.2. Product Portfolio 19.1.6.3. Profitability by Market Segments 19.1.6.4. Sales Footprint 19.1.6.5. Strategy Overview 19.1.6.5.1. Marketing Strategy 19.1.7. Human Motion Technologies LLC 19.1.7.1. Overview 19.1.7.2. Product Portfolio 19.1.7.3. Profitability by Market Segments 19.1.7.4. Sales Footprint 19.1.7.5. Strategy Overview 19.1.7.5.1. Marketing Strategy 19.1.8. Ottobock SE & Co. KGaA (suit X) 19.1.8.1. Overview 19.1.8.2. Product Portfolio 19.1.8.3. Profitability by Market Segments 19.1.8.4. Sales Footprint 19.1.8.5. Strategy Overview 19.1.8.5.1. Marketing Strategy 19.1.9. ExoAtlet 19.1.9.1. Overview 19.1.9.2. Product Portfolio 19.1.9.3. Profitability by Market Segments 19.1.9.4. Sales Footprint 19.1.9.5. Strategy Overview 19.1.9.5.1. Marketing Strategy 19.1.10. Ergosante 19.1.10.1. Overview 19.1.10.2. Product Portfolio 19.1.10.3. Profitability by Market Segments 19.1.10.4. Sales Footprint 19.1.10.5. Strategy Overview 19.1.10.5.1. Marketing Strategy 20. Assumptions & Acronyms Used 21. Research Methodology
Explore Healthcare Insights
View Reports
Medical Exoskeleton Market
